Results 251 to 260 of about 132,203 (308)

A systematic review on vaccine developmental approaches: Evaluating efficacy, and addressing challenges of infectious diseases in the post-COVID-19 era. [PDF]

Virus Res
Sithole MN, Khan MR, Mohammed HA, Khan RA, Naik K, Choonara YE.   +5 more
europepmc   +1 more source

Pathogenic mechanisms and vaccine development for Mycoplasma gallisepticum in chickens. [PDF]

Front Microbiol
Chen J, Liu P, Chen Y.
europepmc   +1 more source

Safety of Sabin Inactivated Poliovirus Vaccine Administered Standalone or Concomitantly with Other Childhood Vaccines: A Real-World Study in China. [PDF]

Vaccines (Basel)
Wang B, Meng F, Xue W, Su Y, Jiang T, Dong Y, Ren M, Tang J.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An inactivated vaccine against ringworm

Comparative Immunology, Microbiology and Infectious Diseases, 1992
A new vaccine against ringworm, containing the inactivated Trichophyton verrucosum strain, was assessed on guinea pigs and calves under experimental conditions and on three herds of cattle under natural conditions. The vaccine elicited a distinct immune response of the cellular type.
K, Wawrzkiewicz, J, Wawrzkiewicz
openaire   +2 more sources

Inactivated virosome hepatitis A vaccine

The Lancet, 1994
Immunopotentiating reconstituted influenza virosomes (IRIV) are efficient carrier systems for small virion particles such as hepatitis A virus (HAV). We evaluated immunogenicity and tolerability of an IRIV-HAV vaccine and the effectiveness of a booster by immunising 104 healthy HAV seronegative volunteers. A single dose was highly immunogenic, since 98%
L, Loutan, P, Bovier, B, Althaus, R, Glück   +3 more
openaire   +2 more sources

Inactivated Poliovirus Vaccine

Human Vaccines, 2007
Subhash C, Arya, Nirmala, Agarwal
openaire   +2 more sources

Polio Vaccines— Live or Inactivated?

JAMA: The Journal of the American Medical Association, 1966
To the Editor:— Two excellent vaccines are in current use to protect against poliomyelitis. Inactivated poliomyelitis vaccine (IPV) developed by Salk has been widely used since 1955. IPV is characterized by complete safety, imperfect immunizing power, and the need for percutaneous administration.
openaire   +2 more sources